About Repro-Med Systems (OTCMKTS:REPR)
REPRO MED SYSTEMS, INC. (RMS) designs, manufactures and markets medical devices for the ambulatory infusion market and emergency medical applications. The Company's products include FREEDOM60 Syringe Infusion System (FREEDOM60), RMS HIGH-Flo Subcutaneous Safety Needle Sets (HIgH-Flo), RES-Q-VAC Portable Medical Suction System (RES-Q-VAC) and On-Line Calculator. The FREEDOM60 consists of the FREEDOM60 Syringe Infusion Pump and RMS Precision Flow Rate Tubing. The HIgH-Flo is designed for self-administration of medicine under the skin. The RES-Q-VAC is a hand-operated suction device that removes fluids from a patient's airway by attaching the RES-Q-VAC pump to various sterile and non-sterile single-use catheters sized for adult and pediatric suctioning. The On-Line Calculator is a tool to help determine which of the Company's Precision Flow Rate Tubing and RMS HIgH-Flo Subcutaneous Needle Sets are to be used based on the medication being administered and time of infusion.
Industry, Sector and Symbol
Industry Medical Instruments & Supplies
Trailing P/E Ratio98
Forward P/E RatioN/A
Sales & Book Value
Annual Sales$12.24 million
Price / Sales2.97
Cash Flow$0.01 per share
Price / Cash154.14
Book Value$0.18 per share
Price / Book5.33
Return on EquityN/A
Return on AssetsN/A
Repro-Med Systems (OTCMKTS:REPR) Frequently Asked Questions
What is Repro-Med Systems' stock symbol?
Repro-Med Systems trades on the OTCMKTS under the ticker symbol "REPR."
Who are some of Repro-Med Systems' key competitors?
Some companies that are related to Repro-Med Systems include Aptose Biosciences (APTO), Versartis (VSAR), Catasys (CATS), Applied Genetic Technologies (AGTC), Novelion Therapeutics (NVLN), Aptevo Therapeutics (APVO), Arch Therapeutics (ARTH), Brainstorm Cell Therapeutics (BCLI), Joint (JYNT), PURE Bioscience (PURE), Histogenics (HSGX), Presbia (LENS), Affimed (AFMD), Cancer Genetics (CGIX), Digirad (DRAD), TRACON Pharmaceuticals (TCON), Cardiome Pharma (CRME) and PLx Pharma (PLXP).
Who are Repro-Med Systems' key executives?
Repro-Med Systems' management team includes the folowing people:
- Andrew I. Sealfon, Chairman of the Board, President (Age 70)
- Fred Ma, Principal Executive Officer
- Karen Fisher, Chief Financial Officer, Treasurer (Age 50)
- David W. Anderson, Director (Age 63)
- Paul Mark Baker, Director (Age 65)
- Joseph M. Manko Jr., Additional Director (Age 50)
- Mark L. Pastreich, Director (Age 86)
- Arthur J. Radin CPA., Director (Age 79)
Who owns Repro-Med Systems stock?
How do I buy Repro-Med Systems stock?
Shares of Repro-Med Systems can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Repro-Med Systems' stock price today?
One share of Repro-Med Systems stock can currently be purchased for approximately $0.96.
How big of a company is Repro-Med Systems?
Repro-Med Systems has a market capitalization of $37.17 million and generates $12.24 million in revenue each year. Repro-Med Systems employs 69 workers across the globe.
How can I contact Repro-Med Systems?
Repro-Med Systems' mailing address is 24 CARPENTER RD, CHESTER NY, 10918. The company can be reached via phone at 845-469-2042 or via email at [email protected]
MarketBeat Community Rating for Repro-Med Systems (REPR)MarketBeat's community ratings are surveys of what our community members think about Repro-Med Systems and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Repro-Med Systems (OTCMKTS:REPR) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Repro-Med Systems (OTCMKTS:REPR) Earnings History and Estimates Chart
Repro-Med Systems (OTCMKTS REPR) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
Repro-Med Systems (OTCMKTS:REPR) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Repro-Med Systems (OTCMKTS:REPR)
No dividend announcements for this company have been tracked by MarketBeat.com
Repro-Med Systems (OTCMKTS REPR) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 39.00%
Repro-Med Systems (OTCMKTS REPR) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|12/15/2017||Joseph M Jr. Manko||Director||Buy||396,692||$0.89||$353,055.88|| |
|12/12/2017||Joseph M Jr. Manko||Director||Buy||137,225||$0.90||$123,502.50|| |
|12/6/2017||Joseph M Jr. Manko||Director||Buy||50,811||$0.84||$42,681.24|| |
|11/30/2017||Joseph M Jr. Manko||Director||Buy||77,600||$0.82||$63,632.00|| |
|11/28/2017||Joseph M Jr. Manko||Director||Buy||222,710||$0.80||$178,168.00|| |
|11/10/2017||Joseph M Jr. Manko||Director||Buy||128,175||$0.66||$84,595.50|| |
|9/15/2017||Joseph M Jr. Manko||Director||Buy||146,418||$0.50||$73,209.00|| |
|5/30/2017||Joseph M Jr. Manko||Director||Buy||7,353||$0.40||$2,941.20|| |
|2/13/2017||Joseph M Jr. Manko||Director||Buy||30,000||$0.40||$12,000.00|| |
|2/2/2017||Joseph M Jr. Manko||Director||Buy||40,000||$0.41||$16,400.00|| |
|1/27/2017||Joseph M Jr. Manko||Director||Buy||7,700||$0.43||$3,311.00|| |
|1/25/2017||Joseph M Jr. Manko||Director||Buy||15,000||$0.41||$6,150.00|| |
|1/23/2017||Joseph M Jr. Manko||Director||Buy||45,000||$0.42||$18,900.00|| |
|1/17/2017||Joseph M Jr. Manko||Director||Buy||5,000||$0.42||$2,100.00|| |
|1/9/2017||Joseph M Jr. Manko||Director||Buy||22,500||$0.43||$9,675.00|| |
|1/3/2017||Joseph M Jr. Manko||Director||Buy||321,821||$0.47||$151,255.87|| |
|11/9/2016||Joseph M Jr. Manko||Director||Buy||9,700||$0.41||$3,977.00|| |
|11/4/2016||Joseph M Jr. Manko||Director||Buy||30,000||$0.41||$12,300.00|| |
|10/31/2016||Joseph M Jr. Manko||Director||Buy||25,400||$0.44||$11,176.00|| |
|10/18/2016||Joseph M Jr. Manko||Director||Buy||9,000||$0.41||$3,690.00|| |
|10/14/2016||Joseph M Jr. Manko||Director||Buy||10,100||$0.43||$4,343.00|| |
|10/11/2016||Joseph M Jr. Manko||Director||Buy||10,000||$0.42||$4,200.00|| |
|10/10/2016||Joseph M Jr. Manko||Director||Buy||32,500||$0.43||$13,975.00|| |
|10/3/2016||Joseph M Jr. Manko||Director||Buy||10,000||$0.43||$4,300.00|| |
|9/30/2016||Joseph M Jr. Manko||Director||Buy||136,248||$0.44||$59,949.12|| |
|8/15/2016||Joseph M Jr. Manko||Director||Buy||30,000||$0.44||$13,200.00|| |
|8/11/2016||Joseph M Jr. Manko||Director||Buy||20,000||$0.44||$8,800.00|| |
|8/1/2016||Joseph M Jr. Manko||Director||Buy||29,000||$0.45||$13,050.00|| |
|7/28/2016||Joseph M Jr. Manko||Director||Buy||20,000||$0.43||$8,600.00|| |
|7/26/2016||Joseph M Jr. Manko||Director||Buy||61,300||$0.43||$26,359.00|| |
|7/21/2016||Joseph M Jr. Manko||Director||Buy||18,800||$0.44||$8,272.00|| |
|7/12/2016||Joseph M Jr. Manko||Director||Buy||10,000||$0.44||$4,400.00|| |
|7/7/2016||Joseph M Jr. Manko||Director||Buy||10,000||$0.44||$4,400.00|| |
|7/6/2016||Joseph M Jr. Manko||Director||Buy||30,000||$0.44||$13,200.00|| |
|4/11/2016||Joseph M Jr. Manko||Major Shareholder||Buy||15,000||$0.31||$4,650.00|| |
|2/16/2016||Joseph M Jr. Manko||Major Shareholder||Buy||21,900||$0.45||$9,855.00|| |
|2/1/2016||Joseph M Jr. Manko||Major Shareholder||Buy||28,800||$0.45||$12,960.00|| |
|1/28/2016||Joseph M Jr. Manko||Major Shareholder||Buy||37,345||$0.41||$15,311.45|| |
|1/26/2016||Joseph M Jr. Manko||Major Shareholder||Buy||34,500||$0.42||$14,490.00|| |
|1/22/2016||Joseph M Jr. Manko||Major Shareholder||Buy||44,934||$0.41||$18,422.94|| |
|4/16/2013||Remo Spagnoli||Director||Buy||10,000||$0.22||$2,200.00|| |
Repro-Med Systems (OTCMKTS REPR) News Headlines
|Repro-Med Systems, Inc. (REPR) Director Joseph M. Jr. Manko Buys 396,692 Shares|
www.americanbankingnews.com - December 15 at 9:22 PM
|Repro-Med Systems, Inc. (REPR) Director Joseph M. Jr. Manko Acquires 137,225 Shares|
www.americanbankingnews.com - December 12 at 9:08 PM
|Insider Buying: Repro-Med Systems, Inc. (REPR) Director Buys 50,811 Shares of Stock|
www.americanbankingnews.com - December 7 at 6:44 PM
|Insider Buying: Repro-Med Systems, Inc. (REPR) Director Buys 77,600 Shares of Stock|
www.americanbankingnews.com - December 1 at 10:50 PM
|Repro-Med Systems, Inc. (REPR) Director Buys $178,168.00 in Stock|
www.americanbankingnews.com - November 28 at 7:52 PM
|Repro-Med Systems Inc.: RMS Medical Products Announces New FDA Clearance, Warning Letter Closed, and Organizational Changes|
www.finanznachrichten.de - November 23 at 8:06 AM
|RMS Medical Products Announces New FDA Clearance, Warning Letter Closed, and Organizational Changes|
finance.yahoo.com - November 23 at 8:06 AM
|CORRECTION: RMS Medical Products Announces New FDA Clearance, Warning Letter Closed, and Organizational Changes|
finance.yahoo.com - November 23 at 8:06 AM
|RMS Medical Products Posts Strong Results for Three and Seven Months Ending September 30, 2017|
finance.yahoo.com - November 18 at 11:19 AM
|Joseph M. Jr. Manko Buys 128,175 Shares of Repro-Med Systems Inc. (REPR) Stock|
www.americanbankingnews.com - November 13 at 6:30 PM
Repro-Med Systems (OTCMKTS:REPR) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Repro-Med Systems (OTCMKTS:REPR) Income Statement, Balance Sheet and Cash Flow Statement
Repro-Med Systems (OTCMKTS REPR) Stock Chart for Saturday, January, 20, 2018